1/141
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
definition of anxiety
· psychological, physiological, and behavioral state in animals and humans (normal)
o Caused by perceived threat to well-being or survival
o Facilities coping with adverse or unexpected situations
what are the 4 types of anxiety-related disorders?
· Generalized anxiety disorder (GAD)
· Panic disorder (PD)
· Social anxiety disorder (SAD)
· Posttraumatic stress disorder (PTSD) --> not truly an anxiety disorder
DSM-5 criteria for GAD
· Excessive anxiety and worry lasting at least 6 months and difficulty controlling the worry
· At least 3 of the following symptoms
o Feeling keyed up or on edge, unsettled
o Becoming easily exhausted
o Mind going blank, difficulty focusing
o Impatience
o Muscle tension
o Sleep disturbance, usually insomnia
· Focus of the anxiety and worry are not caused by another anxiety or psychiatric disorder
· Significant distress or functional impairment because of anxiety symptoms
· Symptoms are not caused by a substance or general medical condition
psychological and cognitive signs and symptoms of GAD
· Excessive anxiety
· Worries that are difficult to control
· Feeling keyed up or on edge
· Poor concentration or mind going blank
· Restlessness
Irritability
physical signs and symptoms of GAD
· Fatigue
· Muscle tension
Sleep disturbance
impairing signs and symptoms of GAD
· Social, occupational or other important functional areas
Poor coping skills
Hamilton Anxiety Scale (HAM-A) reduction in symptoms for remission
>70% (or score <7)
HAM-A reduction in symptoms for improved clinical response
50-70%
HAM-A reduction in symptoms for partial clinical response
25-49%
HAM-A reduction in symptoms for non-response
<25%
risk factors for GAD
-gender (females>>)
-medications, herbal products, supplements (can worsen or even cause)
-medical conditions
· Socioeconomic and ethnic factors
· Recent stressful event
· Genetics
medications, herbal products, and supplements that can worsen or cause GAD
o Caffeine
o Corticosteroids
o Bupropion
o Stimulants
o Bronchodilators
o Decongestants
o Dopamine agonists
o Thyroid hormone
o Ginseng
o St. John's wort
o Nicotine
o Yohimbe
medical conditions that can cause GAD
o Cardio vascular
o Endocrine/metabolic
o Neurologic
o Respiratory
o Menopause/estrogen deficiency
where is GAD often treated?
in the primary care setting
clinical course of GAD
o Can occur at any age (avg is 35)
o Symptoms wax and wane
o >50% of pts with GAD will have a major depressive episode
what are the first-line treatments for GAD
SSRIs and SNRI's
what are the second-line treatments for GAD
o Alternative 1st line agent
o CBT (adjunct)
o Pregabalin
o Vilazodone
o Benzodiazepine
o Buspirone
what are the third-line treatments for GAD
o Alternative 2nd line agent
o Antihistamine (hydroxyzine)
o Second-generation antipsychotic, valproate, trazodone, TCA, vortioxetine
treatment pathway for GAD
SSRIs with the most evidence for treating GAD
-paroxetine
-escitalopram
-citalopram
-setraline
SNRIs with the most evidence for terating GAD
-venlafaxine
-desvenlafaxine
antidepressant onset and titration for GAD
o 4-12 weeks for response in GAD
o Many pts won't achieve remission
o Antidepressants may initially worsen anxiety symptoms consider starting at a lower dose
what line of teratment is CBT for GAD
2nd line
CBT efficacy as a 2nd line treatment of GAD
o Most effective psychological therapy
o Identify negative thought patterns that provoke or worsen anxiety symptoms
o Can be limited by cost, time requirement, availability of trained therapists
o Pharmacotherapy has shown to be more effective than psychotherapy
what type of therapy is most effective for GAD
pharmacotherapy>> psychotherapy
what's a precaution to consider with pregabalin
there is abuse/misuse potential especially in people with a history of SUD
onset of pregabalin
rapid ~1 week
ADRs of pregabalin
-dizziness
-somnolence
-ataxia
-blurred vision
-withdrawal with abrupt discontinuation
what line of therapy are benzodiazepiens for GAD
they are 2nd line but often prescibed because they provide rapid relief (30-60 mins)
precautions to know for benzodiazepine use in GAD
o Long term use is not recommended due to dependence and withdrawal symptoms
§ Withdrawal can occur after taking it for 4-6 weeks
§ Rebound anxiety
what is rebound anxiety
immediate, transient return of anxiety symptoms with increased anxiety compared to baseline when stopping consistent use of a benzodiazepine
rules for benzodiazepines
o May initiate benzos when starting an antidepressant for GAD until antidepressant begins to take effect (limit 2-3 weeks) or for treatment-resistant GAD
o Avoid if history of SUD
o Not effective for depression and may worsen depression/PTSD with long-term use
BZDs and depression
not effective and may worsen depression/PTSD with long-term use
which benzos are misused the most and why
diazepam because they have a rapid onset of action
adverse CNS effects of benzodiazepines
· Drowsiness, sedation
· Psychomotor impairment--> falls
· Disorientation, confusion
· Depression
· Irritability
Memory impairment
abuse, dependence, and withdrawal effects with benzodiazpeines
· High potential for abuse (CIV) especially if history of SUD
· Withdrawal symptoms
· Anxiety
· Insomnia
· Restlessness
· Muscle tension
· Irritability
Seizures (high dose, long duration of therapy, concurrent use with meds that lower seizure threshold)
abuse and benzodiazepines, who should you be cautious about giving these to?
people with a history of SUD because they have high abuse potential
what schedule are benzos?
CIV
which benzodiazepines are safe in patients with hepatic impairment?
· lorazepam, oxazepam, temazepam (LOT)
which drugs have additive CNS and respiratory depression when used with benzos?
alcohol and opioids
which drugs cause a decrease in concentraion of benzodiazepines
-phenytoin
-carbamazepine
-phenobarbital
which durgs cause an increase in concentration of benzodiazepines
CYP3A4 inhibitors (like fluoxetine)
may need to decrease the dose with these
what is the goal of benzo discontinuation
avoid withdrawal symptoms including seizures
tapering off of benzodiazepines
· Reduce dose by 25% per week until 50% of dose is reached
o Then reduce dose by 1/8 every 4-7 days
>8 weeks of BZD therapy, what is the optimal taper duration?
2-3 weeks
>6 months of BZD therapy, what is the optimal taper duration?
4-8 weeks
>1 year of BZD therapy, what is the optimal taper duration?
2-4 months
switchign meds in anxiety disorders, what should you do first if 1 first-line doesn't work?
o First try an alternative 1st-line med before switching to 2nd line
what line of teratment is busprione in GAd
2nd line
buspar generic name
buspirone
lyrica generic name
pregabalin
onset of buspirone in GAD
o Onset may take 2 weeks but full effect may take 4-6 weeks
long-term efficacy of busprione
inconsistent evidence of long-term efficacy
busprione is less likley to be effective if the patient has used ___ within the last ___
if they have used benzos within the last month
ADRs of busprione
dizziness, nausea, headache
initial dose of busprione
7.5mg BID
what patients is buspirone not recommended in?
hepatic or renal impairment
hydroxyzine brand names
atarax and vistaril
what line of treatment is hydroxyzine for GAD
3rd line
when can hydroxyzine be taken?
Symptomatic (prn) relief of anxiety or scheduled
ADRs of hydroxyzine
anticholineric and antihistamine effects including sedation
treatment duration for GAD
· Duration: >/=12 months after treatment response
· Gradually taper off of dose
panic disorder criteria
· recurrent unexpected panic attacks with >/= 1 attack followed by at least 1 month of more than 1 of the following
o Constant concern about having another attack
o Being anxious about the implications of the attack or its consequences
o Maladaptive behavior changes to avoid having panic attack
panic attack vs panic disorder
if you have one panic attack it doesn't necessarily mean you have panic disorder
agoraphobia criteria
· fear or anxiety in >/=2 of the following situations
o Public transportation
o Open spaces
o Enclosed places
o Crowds or standing in line
o Outside of home alone
phsychological symptoms of a panic attack
-depersonalization
-derealization
-fear or losing control, going crazy, dying
physical symptoms of panic attacks
o Abdominal distress, nausea
o Chest pain, palpitations, tachycardia
o Chills, hot flashes, sweating
o Dizziness, light-headedness
o Feeling of choking
o Shortness of breath
o Trembling or shaking
risk factors for panic disorder
o Gender (female more likely)
o Medications, herbal products, supplements (same as GAD)
o Environmental triggers
o Stressful life events
o Smoking
o Genetics (1st degree relative)
clinical course of PD
o Frequency of panic attacks may wax and wane in response to stressors
§ Most pts need long-term treatment
o 1/3 of pts achieve remission
o 1/5 of patients have chronic PD
what factors can predict chronic panic disorder
§ Long duration of illness
§ Severe agoraphobia
§ Comorbid personality, mood, or other anxiety disorders
§ Excessive sensitivity to physical symptoms
PD
panic disorder
first-line treatment for PD
· psychotherapy (CBT, exposure therapy) AND/OR medications (SSRI’s or venlafaxine)
o SSRI’s are equal efficacy- significant improvement in panic severity, anticipatory anxiety, agoraphobia, disability, and quality of life
o Pts may be hypersensitive to ADRs at initiation of treatment
2nd line treatment for PD
o Alt first-line agents
o Benzos for residual anxiety of rapid symptom control (if no SUD history)
o TCA’s- used if SSRI’s or venlafaxine is ineffective, but they have more side effects
o Exercise
when should benzos not be used as monotherapy
if pt has comorbid depression
which benzos are most commonly prescribed for PD?
alprazolam and clonazepam
third-line treatment of PD
o Alt 2nd-line agent
o Phenelzine (MAOI)
treatment goals of PD
o Reduce frequency and severity of panic attacks
o Reduce anticipatory anxiety, fear-driven avoidance, and impaired functioning
onset of antidepressant efficacy in PD
3-4 weeks (may be >6 months for full remission)
onset of BZD efficacy in PD
reduce acute anxiety within hours but may take. 4-6 weeks for full benefit as a monotherapy
duration of PD acute phase of therapy
1-4 months --> change treatment if no response after 12 weeks at max tolerated dose
duration of PD maintenance phase of therapy
continue for 12 months after treatment response
duration of PD discontinuation phase of therapy
depends on pt but taper over 4-6 months to avoid relapse
DSM-5 criteria for social anxiety disorder
· Significant anxiety/fear about at least 1 social situation where individual is exposed to possible scrutiny by others
· Fears they will display anxiety symptoms or act in a way that will be negatively assessed
· Social situations cause anxiety or fear
· Social situations are avoided or experienced with anxiety/fear
· Anxiety/fear > actual threat posed by the social situation
· Anxiety/fear/avoidance persists for >/= 6 months
· Symptoms cause impairment or distress
· Symptoms not caused by substance
· Symptoms> what would be expected from comorbid medical conditions
what must be specified about social anxiety disorder according to DSM-5 criteria?
must specify if it's performance-only social anxiety
fears of social anxiety disorder
- Scrutinized by others
- Embarrassment
Humiliation
feared situtations of social anxiety disorder
- Public speaking
- Eating/drinking in front of others
- Interacting with authority figures
- Talking with strangers
Use of public restrooms
physical symptoms of social anxiety
- Blushing
- "butterflies"
- Diarrhea
- Sweating
- Tachycardia
trembling
risk factors for social anxiety
· psych comorbidity
· genetics ( 1st-degree relative)
· familial factors (parental overcontrol)
· early childhood anxiety disorders
· life stressors
onset vs treatment of social anxiety
onset is usually 14-16 years old but treatment is delayed by about 10 years
comorbid conditions with social anxiety
anxiety, depression, SUD
pathophysiology of performance-only subtyoe of social anxiety
NE syetm dysfunction
SAD
social anxiety disorder
pathophysiology of general SAD
o decreased D2 receptor binding
o low DA metabolite levels--> higher incidence of SAD in Parkinson's pts and during antipsychotic treatment
o hypersensitive 5-HT2 receptors
first-line treatment of SAD
o CBT
o SSRI’s
§ Improve anxiety, avoidance, and disability
o Venlafaxine
which SNRIs are first-line for SAD
venlafaxine only
which SSRIs are first-line for SAD
paroxetine, sertraline, escitalopram, fluvoxamine
2nd-line treatment of SAD
o Alt 1st line agent
o Pregabalin
o Mirtazapine
o Gabapentin
efficacy of benzos/ antipsychotics in SAD
little evidence to support augmentation with benzos or antipsychotics but may be an option in pts with partial response
treatment options for performance-related SAD
beta blockers- propanolol and atenolol
what do beta blockers do in performance-related SAD pts
decrease tremor palpitations and blushing